Brief India: APAC Healthcare Weekly (October 26) – Innovent, Akeso, Celltrion, Classys, Daiichi, Syngene, Cipla and more
In this briefing: APAC Healthcare Weekly (October 26) – Innovent, Akeso, Celltrion, Classys, Daiichi, Syngene, Cipla Emirates NBD’s Entry Redefines RBL Bank’s Growth Trajectory Axis PUNCH: Garware Hi-Tech Films Ltd - 24th October, 2025 Hindustan Unilever Ltd - GST Transition Led to Short-Term Impact; Maintain HOLD Colgate Palmolive (India) Ltd - Miss on All Fronts; Gradual Recovery Ahead 1. APAC Healthcare Weekly (October 26) – Innovent, Akeso, Celltrion, Classys, Daiichi, Syngene, Cipla Innovent Biologics announced strategic global collaboration with Takeda for total deal value of $11.4B. Akeso announced that phase 3 trial evaluating ivonescimab versus tislelizumab in sq-NSCLC met primary endpoint. Celltrion received FDA approval for two additional pediatric indications for Humira biosimilar, Yuflyma. Classys plans to acquire 77.5% stake in JL Health, South American energy-based aesthetic medical device distribution group. Syngene plans to add a bioconjugation suite at its commercial biologics facility.